HUABIO

Leading Antibody Service Provider. Empowered by four core technology platforms — Single B Cell-Based Recombinant Antibody Platform, Hybridoma Monoclonal Antibody Platform, Comprehensive Antibody Validation Platform, and High-Throughput Protein & Antibody Production Platform. We specialise in developing high-sensitivity and high-specificity antibodies by a top-tier scientific team. With over 10,000 antibody projects completed, our solutions support research across 30+ model organisms and have contributed to thousands of SCl publications, including Cell, Nature, and Science. Delivering research-grade quality to advance life science discovery.